|
Originally published In Press as doi:10.1074/jbc.M206032200 on July 12, 2002
J. Biol. Chem., Vol. 277, Issue 39, 35815-35818, September 27, 2002
Differential Sensitivity of Inward Rectifier K+
Channels to Metabolic Inhibitors*
Anthony
Collins and
Maureen
Larson
From the Department of Pharmaceutical Sciences, College of
Pharmacy, Oregon State University, Corvallis, Oregon 97331-3507
Received for publication, June 18, 2002, and in revised form, July 8, 2002
 |
ABSTRACT |
Inhibition of inward rectifier
K+ channels under ischemic conditions may contribute
to electrophysiological consequences of ischemia such as cardiac
arrhythmia. Ischemia causes metabolic inhibition, and the use of
metabolic inhibitors is one experimental method of simulating ischemia.
The effects of metabolic inhibitors on the activity of inward rectifier
K+ channels Kir2.1, Kir2.2, and
Kir2.3 were studied by heterologous expression in
Xenopus oocytes and two-electrode voltage clamp. 10 µM carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP) inhibited
Kir2.2 and Kir2.3 currents but was without
effect on Kir2.1 currents. The rate of decline of current
in FCCP was faster for Kir2.3 than for Kir2.2.
Kir2.3 was inhibited by 3 mM sodium azide
(NaN3), whereas Kir2.1 and Kir2.2
were not. Kir2.2 was inhibited by 10 mM
NaN3. All three of these inward rectifiers were inhibited by lowering the pH of the solution perfusing inside-out membrane patches. Kir2.3 was most sensitive to pH
(pK = 6.9), whereas Kir2.1 was least
sensitive (pK = 5.9). For Kir2.2 the
pK was 6.2. These results demonstrate the differential
sensitivity of these inward rectifiers to metabolic inhibition and
internal pH. The electrophysiological response of a particular cell
type to ischemia may depend on the relative expression levels of
different inward rectifier genes.
 |
INTRODUCTION |
Inward rectifier K+ channels are known to be involved
in the electrophysiology of several different tissues, including the heart (1). In fast response myocardial tissue they are responsible for
the relatively negative value of the resting membrane potential and the
late rapid repolarization phase of the action potential (2). Their
characteristic property of inward rectification allows the myocardial
cell to generate long lasting action potentials while minimizing ion
fluxes (3).
Ischemia produces electrophysiological changes that can lead to the
generation of cardiac arrhythmias (4) or cerebral excitotoxicity (5).
Simulated ischemia has been shown to inhibit an inwardly rectifying
current in isolated cardiac myocytes (6). This effect may contribute to
arrhythmogenesis and is therefore worthy of further study. Three
closely related inward rectifier genes, Kir2.1, Kir2.2, and Kir2.3, are expressed in myocardium
(7, 8), so each of these could potentially be involved in the
aforementioned ischemic response in the heart. These genes are also
expressed in the brain (9-11). In this report we have simulated
ischemia by applying metabolic inhibitors to Xenopus oocytes
expressing these three inward rectifier K+ channels. We
show that Kir2.1, Kir2.2, and
Kir2.3 are affected differently by metabolic inhibition. We
also show that the sensitivity of Kir2.2 to internal pH is
intermediate between that of Kir2.1 and
Kir2.3.
 |
EXPERIMENTAL PROCEDURES |
Subcloning and in Vitro Transcription--
Complementary DNAs
encoding Kir2.1 (IRK1) (9), Kir2.2 (MB-IRK2)
(11), and Kir2.3 (MB-IRK3) (10) were subcloned into the
Xenopus expression vector pGEMHE (12). Plasmids were
linearized with NheI, and cRNA was transcribed in
vitro with T7 RNA polymerase (mMessage mMachine, Ambion, Austin,
TX). RNA yield and integrity were assessed by agarose-ethidium bromide
gel electrophoresis.
Oocyte Isolation--
Stage V-VI oocytes were surgically
removed from Xenopus laevis frogs (Nasco) under
anesthesia (0.03% benzocaine for 10-15 min) and incubated with 1.3 mg/ml collagenase (Worthington, type CLS3) for 2 h at 22 °C in
96 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 5 mM HEPES, pH 7.4, with agitation to
remove connective tissue. Oocytes were then washed several times with
96 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 1.8 mM CaCl2, 5 mM HEPES, pH 7.4, and stored in the same solution at
18 °C. Both solutions also contained 100 µg/ml streptomycin and 60 µg/ml ampicillin. Between 16 and 24 h later, oocytes were
injected (Nanoliter; World Precision Instruments) with amounts of RNA
that gave approximately equal expression levels (0.2 ng of
Kir2.1, 4 ng of Kir2.2, and 4 ng of
Kir2.3) in 50 nl of nuclease-free water.
Two-electrode Voltage Clamp--
Inward rectifier currents were
recorded 1-2 days after injection using a TEC-03 amplifier (npi,
Germany) controlled by Pulse 8.4 software (Heka, Germany) via
an ITC-16 computer interface (Instrutech, Long Island, NY). Currents
were filtered at 500 Hz and digitized at 1 kHz. Data were analyzed
using Pulse 8.4 and Prism 3.02 (GraphPad). Microelectrode pipettes had
resistances of 0.5-1.5 megohms. Oocytes were placed in a 100-µl
volume recording chamber that was continuously perfused at a rate of
~1.2 ml/min. Different solutions entered the chamber via a common
outlet with a dead space of ~50 µl. Under control conditions
oocytes were perfused with "90K" solution: 90 mM
KCl/KOH, 3 mM MgCl2, 5 mM HEPES, pH
7.4. Sodium azide (NaN3) and BaCl2 were
dissolved in aliquots of this solution as solid. Carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP)1 (ICN, Costa Mesa, CA)
was dissolved in dimethyl sulfoxide (Me2SO) to 100 mM. This stock solution was diluted into 90K.
Patch Clamp Recording--
Inward rectifier currents were
recorded in "giant" inside-out patches from Xenopus
oocytes (13) 3-9 days after injection with
Kir2.x RNA. The patch clamp amplifier was an
Axopatch 200B (Axon Instruments). Currents were filtered at 1 kHz, and
data were acquired at 4.76 kHz with a Digidata 1320A computer interface and pClamp 8 software (Axon Instruments). Data were analyzed using pClamp 8 and Prism 3.02 (GraphPad). Patch pipettes had inner tip diameters of 20-25 µm and contained a "FVPP" type solution (14) (in mM): 40 KCl, 75 potassium gluconate, 5 KF, 0.1 mM NaVO3, 10 sodium pyrophosphate, 1 mM EGTA, 10 glucose, 0.1 spermine, 10 PIPES, pH 7.4, with
HCl. The recording chamber contained this same solution. Inside-out
patches were perfused with this solution and with aliquots of this
solution that had been further adjusted to different pH values with
HCl. Switching between different perfusion solutions was achieved with
a BPS-8 valve control system and a QMM micromanifold with a dead space
of ~1 µl (ALA Scientific Instruments, Westbury, NY). The perfusion
rate was 85 µl/min.
 |
RESULTS |
Effects of FCCP on Inward Rectifier Currents in Intact
Oocytes--
Inward rectifier currents were monitored by means of a
continuous two-electrode voltage clamp protocol. Membrane potential was
held at 0 mV and at 20-s intervals was stepped to 50 mV for 75 ms and
then to 50 mV for 350 ms. Expression of inward rectifier channels was
confirmed by brief application of 20 mM Ba2+,
which completely blocks Kir2.1, Kir2.2, and
Kir2.3 (9-11). Oocytes were first perfused with 90K to
ensure a steady current, and then the perfusion solution was switched
to 90K plus 10 µM FCCP, which inhibits ATP production by
dissipating the H+ gradient across the inner
mitochondrial membrane (15). (This solution also contained 0.01%
Me2SO. Me2SO alone had no effect on
inward rectifier currents at this concentration.)
In oocytes expressing Kir2.1, inward rectifier current
remained steady in the presence of 10 µM FCCP. In
contrast, 10 µM FCCP inhibited inward rectifier current
in oocytes expressing Kir2.2 or Kir2.3.
Examples of these experiments are shown in Fig.
1. To rule out the unlikely possibility
that the decline of Kir2.2 and Kir2.3 currents
was because of spontaneous "rundown," we perfused oocytes
expressing these clones with 90K (plus 0.01% Me2SO) for prolonged periods without switching to FCCP. As shown by the examples in Fig. 2, spontaneous rundown did not
occur. Indeed, in some cases (as in Fig. 2) the current had a tendency
to slowly increase. This was not because of an increase in leak
current, as demonstrated by applying 20 mM
Ba2+.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Examples of FCCP application to
Xenopus oocytes expressing Kir2.1,
Kir2.2, or Kir2.3. FCCP (10 µM) was applied in 90K solution following 1 min, 40 s of perfusion with 90K alone (plus 0.01% Me2SO). Inward
rectifier current was monitored by two-electrode voltage clamp. At 20-s
intervals the membrane potential was stepped from the holding potential
of 0 mV to 50 mV for 75 ms and then to 50 mV for 350 ms. The data in
panel A represent the current recorded at the end of the
50 mV step. After 15 min of FCCP application the oocytes were
briefly exposed to 20 mM Ba2+, which was added
to the 90K solution as BaCl2. Panels B,
C, and D show current traces obtained at the
times indicated by the letters a, b, and
c, for Kir2.1, Kir2.2, and
Kir2.3, respectively. The horizontal
line indicates zero current level.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Examples of prolonged recordings of
Kir2.2 and Kir2.3 currents in the continued
presence of 90K (plus 0.01% Me2SO). The voltage clamp
protocol was the same as in Fig. 1. The data in panel A
represent the current recorded at 50 mV. The oocytes were
briefly exposed to 20 mM Ba2+ at the times
indicated. Panels B and C show current traces
obtained at the times indicated by the letters a,
b, and c, for Kir2.2 and
Kir2.3, respectively. The horizontal
line indicates zero current level.
|
|
Because the rate of decrease of inward rectifier currents in FCCP was
quite slow, we chose an arbitrary time point of 15 min to compare the
response of Kir2.1, Kir2.2, and
Kir2.3 to FCCP. Fig. 3 shows
that there was a significant difference between Kir2.2 and
Kir2.3 in terms of the fractional current remaining after 15 min of exposure to FCCP, demonstrating that the rate of
Kir2.2 current decline was slower than that of
Kir2.3. The fractional Kir2.2 current remaining
after 15 min was significantly different from that of
Kir2.1, which was unaffected by FCCP. In excised membrane
patches, 10 µM FCCP was without effect on
Kir2.2 and Kir2.3 (data not shown).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of the effects of FCCP on
Kir2.1, Kir2.2, and Kir2.3.
Currents were recorded by two-electrode voltage clamp as in Figs. 1 and
2. The current recorded at 50 mV was used for this analysis. Oocytes
were perfused with 90K plus 10 µM FCCP or 90K alone (plus
0.01% Me2SO) for 15 min. The perfusate was then switched
to 90K plus 20 mM BaCl2. The current remaining
in the presence of Ba2+ was subtracted from currents
recorded at the beginning and end of the 15-min interval. The
Ba2+-sensitive current at the end of the 15-min interval
was normalized to the Ba2+-sensitive current at the
beginning of the 15-min interval. A standard t test was used
to compare pairs of data groups. p values are as follows:
p < 0.005 for column 1 versus column 2, column
2 versus column 3, and
column 2 versus column
4; p < 0.0001 for column
3 versus column 5. Bars represent means ± S.E. from 6 oocytes.
|
|
Effects of Sodium Azide on Inward Rectifier Currents in Intact
Oocytes--
To gain further evidence that the effect of FCCP was
because of metabolic inhibition, we tested another metabolic inhibitor, sodium azide (NaN3) (16, 17). Voltage clamp experiments
were carried out using the same protocol as that used for the FCCP experiments. As shown in Fig. 4,
Kir2.3 currents decreased significantly during 15 min of
exposure to 3 mM NaN3, whereas
Kir2.1 and Kir2.2 currents were unaffected by
this treatment. However, Kir2.2 currents were inhibited by
10 mM NaN3.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Comparison of the effects of NaN3
on Kir2.1, Kir2.2, and Kir2.3.
The protocol was the same as for Fig. 3. A standard t test
was used to compare pairs of data groups. p values are as
follows: p < 0.0001 for column 1 versus column 5 and for
column 4 versus column
5; p < 0.05 for column
2 versus column 3. Bars represent means ± S.E. from 6 oocytes.
|
|
Effects of Internal pH on Inward Rectifier Currents in Inside-out
Patches--
It has been reported that metabolic inhibitors decrease
intracellular pH (18, 19). It has also been reported that
Kir2.3 is more sensitive than Kir2.1 to
decreased intracellular pH (14). Therefore the sensitivity of
Kir2.3 to metabolic inhibitors compared with
Kir2.1 is consistent with a decrease in intracellular pH caused by metabolic inhibition. To investigate whether the intermediate sensitivity of Kir2.2 to metabolic inhibitors could be
explained in terms of pH sensitivity, we compared the dose response of
the three inward rectifiers to internal pH in inside-out membrane patches. As shown in Fig. 5, the
sensitivity of Kir2.2 to decreasing pH was intermediate
between that of Kir2.1 and Kir2.3.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of internal pH on
Kir2.1, Kir2.2, and Kir2.3.
A-C, examples of currents recorded in inside-out patches
perfused with solutions of different pH as indicated. Membrane
potential was held at 0 mV and stepped to 50 mV for 63 ms and then to
50 mV for 126 ms. The horizontal line indicates
zero current level. D, pH dependence of current at 50 mV.
Data are from 6 oocytes each. Data points and error bars represent the
mean ± S.E. Currents were normalized to the current in pH 7.4. Curves are the best fits of the data to
I/IpH7.4 = 1/(1 + ([H+]/K)n), where K is the
[H+] at which the current is 50% inhibited and
n is the Hill coefficient. pK values are 5.9, 6.2, and 6.9 for Kir2.1, Kir2.2, and
Kir2.3, respectively. Hill coefficients are 2.2, 2.8, and
3.0 for Kir2.1, Kir2.2, and Kir2.3,
respectively.
|
|
 |
DISCUSSION |
Acute ischemia produces many changes in the intracellular
environment. These changes affect the activity of several different ion
channels, leading to cellular electrophysiological alterations that can
produce arrhythmias in the heart (4) or excitotoxicity in the brain
(5). Inward rectifier K+ channels play an important role in
the electrophysiology of the cardiac myocyte (2, 20), and inhibition of
their activity will have a significant and possibly arrhythmogenic
effect (4). Acute ischemia produces a shortening of the action
potential because of activation of ATP-sensitive K+
channels preceded in some cases by a lengthening. The lengthening has
been attributed to inhibition of the transient outward current accompanied by inhibition of the inward rectifier current in some preparations (6) but not others (21). Further studies are required to
determine the contribution of inward rectifier channels to changes in
action potential duration during ischemia relative to other channel types.
The results presented here suggest that the effect of ischemia on
inward rectifier current will depend on the molecular identity of the
channels. We have demonstrated that the inward rectifiers Kir2.1, Kir2.2, and Kir2.3 are
differentially sensitive to inhibition of cellular metabolism. Because
cellular metabolism is inhibited in ischemia (4), our experimental
conditions simulate some of the conditions prevailing during ischemia.
Therefore it seems reasonable to propose that of these three related
inward rectifiers Kir2.3 will be inhibited the most under
ischemic conditions, whereas Kir2.1 will be inhibited the least.
One of the intracellular changes that occurs during ischemia and
metabolic inhibition is a decrease in pH (4, 18, 19). In this study,
the order of sensitivity of Kir2.1, Kir2.2, and Kir2.3 to metabolic inhibition was the same as the order of
sensitivity to lowering internal pH. However, the relative sensitivity
to metabolic inhibition cannot be accounted for by a change in internal pH alone. For example, the degree of inhibition of Kir2.2
after 15 min of exposure to 10 µM FCCP (15%; Fig. 3,
column 2) corresponds to an internal pH of 6.5 (Fig. 5D), whereas the degree of inhibition of
Kir2.3 after 15 min of exposure to 10 µM FCCP
(38%; Fig. 3, column 3) corresponds to an
internal pH of 7.0 (Fig. 5D). Therefore our results suggest
the influence of other intracellular consequences of metabolic
inhibition. For example, metabolic inhibitors have been shown to
deplete intracellular ATP in Xenopus oocytes (22).
Experimental data and simulations indicate that a change of a few
nanosiemens in the K+ conductance of a cardiac
myocyte can significantly affect action potential duration (23).
Therefore, inhibition of only a fraction of the 150 nanosiemens
inward rectifier conductance in the cardiac myocyte (24) may have a
significant effect in ischemia. In the heart the inward rectifier
current (IK1) is probably because of expression
of both Kir2.1 and Kir2.2 with a small or no
contribution from Kir2.3, depending on the species (7-11,
25). However, the relative functional expression levels of these
different channels are not known accurately. Inward rectifier mRNA
levels have been measured in human heart, but they may not reflect
expression at the functional level (8). Differences in the relative
expression levels of these genes in different anatomical locations in
the heart may produce spatial disparities in the refractory period in
response to ischemia. Such situations are proarrhythmic (4). Details of
the spatial distributions of inward rectifier gene expression in the
heart are unknown at present. As an added complication, it is possible
that Kir2.2 exists as a heteromultimer with
Kir2.1 (25). Although Kir2.3 may not contribute
much to IK1 in the heart, its location in
neurons (26, 27) raises the possibility of a role in ischemia-induced excitotoxicity.
 |
ACKNOWLEDGEMENT |
We thank Dr. Lily Jan for Kir2.1,
Kir2.2, and Kir2.3 clones.
 |
FOOTNOTES |
*
This work was funded in part by the American Heart
Association, Northwest Affiliate.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 15th and Jefferson, Corvallis, OR 97331-3507. Tel.: 541-737-5799; Fax:
541-737-3999; E-mail: tony.collins@orst.edu.
Published, JBC Papers in Press, July 12, 2002, DOI 10.1074/jbc.M206032200
 |
ABBREVIATIONS |
The abbreviations used are:
FCCP, carbonyl
cyanide p-trifluoromethoxyphenylhydrazone;
PIPES, 1,4-piperazinediethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Nichols, C. G.,
and Lopatin, A. N.
(1997)
Annu. Rev. Physiol.
59,
171-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Lopatin, A. N.,
and Nichols, C. G.
(2001)
J. Mol. Cell. Cardiol.
33,
625-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hille, B.
(2001)
Ion Channels of Excitable Membranes
, 3rd Ed.
, pp. 149-152, Sinauer Associates, Sunderland, MA
|
| 4.
|
Carmeliet, E.
(1999)
Physiol. Rev.
79,
917-1017[Abstract/Free Full Text]
|
| 5.
|
Dirnagl, U.,
Iadecola, C.,
and Moskowitz, M. A.
(1999)
Trends Neurosci.
22,
391-397[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Henry, P.,
Popescu, A.,
Puceat, M.,
Hinescu, M. E.,
and Escande, D.
(1996)
Cardiovasc. Res.
32,
930-939[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Liu, G. X.,
Derst, C.,
Schlichthorl, G.,
Heinen, S.,
Seebohm, G.,
Bruggemann, A.,
Kummer, W.,
Veh, R. W.,
Daut, J.,
and Preisig-Muller, R.
(2001)
J. Physiol. (Lond.)
532,
115-126[Abstract/Free Full Text]
|
| 8.
|
Wang, Z.,
Yue, L.,
White, M.,
Pelletier, G.,
and Nattel, S.
(1998)
Circulation
98,
2422-2428[Abstract/Free Full Text]
|
| 9.
|
Kubo, Y.,
Baldwin, T. J.,
Jan, Y. N.,
and Jan, L. Y.
(1993)
Nature
362,
127-133[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Morishige, K.,
Takahashi, N.,
Jahangir, A.,
Yamada, M.,
Koyama, H.,
Zanelli, J. S.,
and Kurachi, Y.
(1994)
FEBS Lett.
346,
251-256[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Takahashi, N.,
Morishige, K.,
Jahangir, A.,
Yamada, M.,
Findlay, I.,
Koyama, H.,
and Kurachi, Y.
(1994)
J. Biol. Chem.
269,
23274-23279[Abstract/Free Full Text]
|
| 12.
|
Liman, E. R.,
Tytgat, J.,
and Hess, P.
(1992)
Neuron
9,
861-871[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hilgemann, D.
(1995)
in
Single-channel Recording
(Sakmann, B.
, and Neher, E., eds), 2nd Ed.
, pp. 307-327, Plenum Press, New York
|
| 14.
|
Qu, Z.,
Zhu, G.,
Yang, Z.,
Cui, N., Li, Y.,
Chanchevalap, S.,
Sulaiman, S.,
Haynie, H.,
and Jiang, C.
(1999)
J. Biol. Chem.
274,
13783-13789[Abstract/Free Full Text]
|
| 15.
|
Benz, R.,
and McLaughlin, S.
(1983)
Biophys. J.
41,
381-398[Medline]
[Order article via Infotrieve]
|
| 16.
|
Vasilyeva, E. A.,
Minkov, I. B.,
Fitin, A. F.,
and Vinogradov, A. D.
(1982)
Biochem. J.
202,
15-23[Medline]
[Order article via Infotrieve]
|
| 17.
|
Tsubaki, M.
(1993)
Biochemistry
32,
174-182[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Tromballa, H. W.
(1981)
Biochim. Biophys. Acta
636,
98-103[Medline]
[Order article via Infotrieve]
|
| 19.
|
Maduh, E. U.,
Borowitz, J. L.,
and Isom, G. E.
(1990)
Toxicol. Appl. Pharmacol.
106,
201-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Shimoni, Y.,
Clark, R. B.,
and Giles, W. R.
(1992)
J. Physiol. (Lond.)
448,
709-727[Abstract/Free Full Text]
|
| 21.
|
Verkerk, A. O.,
Veldkamp, M. W.,
van Ginneken, A. C.,
and Bouman, L. N.
(1996)
J. Mol. Cell. Cardiol.
28,
2443-2456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Gribble, F. M.,
Ashfield, R.,
Ammala, C.,
and Ashcroft, F. M.
(1997)
J Physiol
498,
87-98[Abstract/Free Full Text]
|
| 23.
|
Nichols, C. G.,
and Lederer, W. J.
(1991)
Am. J. Physiol.
261,
H1675-1686[Abstract/Free Full Text]
|
| 24.
|
Sakmann, B.,
and Trube, G.
(1984)
J. Physiol. (Lond.)
347,
641-657[Abstract/Free Full Text]
|
| 25.
|
Zaritsky, J. J.,
Redell, J. B.,
Tempel, B. L.,
and Schwarz, T. L.
(2001)
J. Physiol. (Lond.)
533,
697-710[Abstract/Free Full Text]
|
| 26.
|
Stonehouse, A. H.,
Pringle, J. H.,
Norman, R. I.,
Stanfield, P. R.,
Conley, E. C.,
and Brammar, W. J.
(1999)
Histochem. Cell Biol.
112,
457-465[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Inanobe, A.,
Fujita, A.,
Ito, M.,
Tomoike, H.,
Inageda, K.,
and Kurachi, Y.
(2002)
Am. J. Physiol.
282,
C1396-C1403[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Collins, H. Wang, and M. K. Larson
Differential Sensitivity of Kir2 Inward-Rectifier Potassium Channels to a Mitochondrial Uncoupler: Identification of a Regulatory Site
Mol. Pharmacol.,
April 1, 2005;
67(4):
1214 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hobbs, P. Foster, C. Prescott, R. Scotland, and A. Ahluwalia
Natriuretic Peptide Receptor-C Regulates Coronary Blood Flow and Prevents Myocardial Ischemia/Reperfusion Injury: Novel Cardioprotective Role for Endothelium-Derived C-Type Natriuretic Peptide
Circulation,
September 7, 2004;
110(10):
1231 - 1235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Du, H. Zhang, C. Lopes, T. Mirshahi, T. Rohacs, and D. E. Logothetis
Characteristic Interactions with Phosphatidylinositol 4,5-Bisphosphate Determine Regulation of Kir Channels by Diverse Modulators
J. Biol. Chem.,
September 3, 2004;
279(36):
37271 - 37281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, G. Feller, C. Gerday, and N. Glansdorff
Metabolic Enzymes from Psychrophilic Bacteria: Challenge of Adaptation to Low Temperatures in Ornithine Carbamoyltransferase from Moritellaabyssi
J. Bacteriol.,
April 1, 2003;
185(7):
2161 - 2168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ortenblad and D G. Stephenson
A novel signalling pathway originating in mitochondria modulates rat skeletal muscle membrane excitability
J. Physiol.,
April 1, 2003;
548(1):
139 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|